Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial
PaperCitations, authors & open-access status
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 158 citations, 2024 year and hybrid oa status.
158
Citations
2024
Year
hybrid
OA Status